fcal_turbo_1 Evaluation of the BÜHLMANN fCAL® turbo test at Bioanalytica Lucerne - Interview with the leader of this evaluation study, Yvonne Schallberger about her positive experiences with the BÜHLMANN fCAL® turbo assay and with the CALEX® Cap stool extraction device which has also been used successfully with the ScheBo® Pancreatic Elastase. Click here.  
Exhibition Booth Visit us at UEGW2016 - BÜHLMANN will be present from October 15th to 19th at the 2016 United European Gastro Week Visit us at booth #31 in Hall X2 Exhibtion Highlights: Presentation of the first Infliximab Therapeutic Drug Montioring Point-of-Care Rapid Test Presentation of the first truly random access BÜHLMANN fCAL turbo assay Oral Presentation #OP247: 18 months market experience
Infliximab 950x350 First Publication using our Quantum Blue® Infliximab Trough Level Assay - We are very pleased to announce the publication of the first article describing our Quantum Blue® Infliximab trough level assay. The authors around Professor F. Magro claim that: “On the basis of this study, we may conclude that the point-of-care Quantum Blue is a reliable alternative to the time-consuming ELISAs, allowing the fast and accurate assessment of